THE CHINESE UNIVERSITY OF HONG KONG FACULTY OF MEDICINE
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
CU Medicine study published in The Lancet Infectious Diseases concludes that a novel oral microencapsulated live bacteria consortia (SIM01) alleviates long COVID symptoms 2023-12-08 10:38
CU Medicine develops novel microbiome technology MOZAICTM for faecal microbiota transplantation 2023-11-16 17:26
A random placebo-controlled clinical trial by CU Medicine shows that modulation of gut microbiome using oral microencapsulated live bacteria (SIM01) improves long COVID symptoms 2023-05-22 16:37
Large-scale clinical study shows CU Medicine (SIM01) microbiome formula reduces risk of infections including COVID-19 2022-10-24 17:59
CUHK researchers discover distinct gut microbial signatures for prediction, diagnosis and treatment of long COVID 2022-04-11 12:35
Joint CUHK-HKU study discovers efficacy of COVID-19 vaccines correlates with a probiotic bacterium, Bifidobacterium adolescentis 2021-12-02 21:00
CUHK Discovers Children with Autism Have Delayed Gut Microbiome Maturity and Identifies Faecal Bacterial Markers for Autism 2021-08-05 16:40
CUHK Develops a Novel Faecal Test that can Detect Polyps and Early Colon Cancers with Sensitivity Over 90% 2021-07-28 15:09
CUHK Microbiome Immunity Formula Hastens Recovery of COVID-19 Patients and Offers Hope to Boost Immunity 2020-11-19 17:13
CU Medicine Develops a Probiotic Formula to Target Imbalance in Gut Microbiota in COVID-19 2020-06-11 20:33
1